Boc-Lys(Z)-OSu

Catalog No. :
ACVOCG407
CAS No. :
34404-36-9
Molecular Formula :
C23H31N3O8
Molecular Weight :
477.51

IUPAC Name:2,5-dioxopyrrolidin-1-yl N6-((benzyloxy)carbonyl)-N2-(tert-butoxycarbonyl)-L-lysinate

Boc-Lys(Z)-OSu structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g96%$172.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBoc-Lys(Z)-OSu
IUPAC Name2,5-dioxopyrrolidin-1-yl N6-((benzyloxy)carbonyl)-N2-(tert-butoxycarbonyl)-L-lysinate
MDL No.MFCD00037915
Molecular FormulaC23H31N3O8
Molecular Weight477.51
SMILESO=C(ON1C(CCC1=O)=O)[C@@H](NC(OC(C)(C)C)=O)CCCCNC(OCC2=CC=CC=C2)=O
InChI KeyYWLICOCXPNQJPC-KRWDZBQOSA-N
SynonymBoc-Lys(Z)OSu | Boc-Lys-(Z)-OSu | Boc-Lys(Z)-OSu | MFCD00037915 | (S)-2,5-Dioxopyrrolidin-1-yl 6-(((benzyloxy)carbonyl)amino)-2-((tert-butoxycarbonyl)amino)hexanoate | DS-14203 | (2,5-dioxopyrrolidin-1-yl) (2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-6-
CAS No.34404-36-9
PubChem CID12686578

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACVOCG407 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDKPF416 route compound structure diagram
    ACDKPF41655878-47-2 In Stock
  2. Plus
  3. ACPOQL635 route compound structure diagram
    ACPOQL6356066-82-6 In Stock
  4. Then
  5. ACVOCG407 route product structure diagram
    ACVOCG40734404-36-9 In Stock
Inquiry

2. ACVOCG407 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOIRG295 route compound structure diagram
    ACOIRG2952389-45-9 In Stock
  2. Plus
  3. ACPOQL635 route compound structure diagram
    ACPOQL6356066-82-6 In Stock
  4. Then
  5. ACVOCG407 route product structure diagram
    ACVOCG40734404-36-9 In Stock
Inquiry

Comments (0)